
Antimicrobial Prophylaxis in Pregnancy - Phase 1: Stakeholder mapping and patient journey mapping
Women’s & Reproductive Health (Obstetrics & Gynecology), Infectious Diseases & Immunology
2022-09-14 – 2025-03-31
Prophylactic antibiotic use in pregnancy is essential to prevent serious complications such as early-onset neonatal Group B Streptococcus (GBS) disease and surgical site infections following cesarean delivery. While penicillin is the first-line treatment—and cefazolin a recommended alternative—many patients with a documented penicillin allergy receive less effective second-line antibiotics. This is often due to outdated information or inaccurate allergy labels, despite evidence that up to 98% of individuals reporting a penicillin allergy are not truly allergic.
Optimizing antimicrobial use in pregnancy is critical to improving outcomes for both mothers and infants. This multi-phase project aims to better understand current practices and gaps in care to inform targeted knowledge translation and intervention strategies that support appropriate, evidence-based antibiotic use. The project is led by PLP Medical Director Dr. Eliana Castillo, in collaboration with Dr. Lynora Saxinger and the AHS Antimicrobial Stewardship group.
For the first phase of this project, we undertook a stakeholder mapping activity by engaging with relevant stakeholders in this space to inform the study design and extend the network for dissemination of this work. We engaged with individual and organizational stakeholders across the care continuum, in rural and urban settings, and across a range of obstetrical team roles. We met with obstetrical networks, associations, and organizations, including the AHS Maternal, Newborn, Child, and Youth Strategic Clinical Network (i.e., MNCY SCN).
Using human centred design approaches, we developed a patient journey map that illuminates the perinatal process of a patient that qualifies for antibiotic prophylaxis and their care. The goal was to understand the process(es) related to prenatal allergy identification, reaction risk assessment, documentation, and communication across the care continuum. In addition to interviewing family physicians, obstetricians, obstetrical nurses, midwives and residents, we reviewed a broad range of documents, including processes, policies, and documentation, including prenatal records, standing order sets, and electronic documentation across and within the care continuum. Through this clinical process mapping activity, we found that nurses and pharmacists play crucial roles in documenting and reviewing reported allergy assessments, although without detailed investigation to assess the nature of the immune reaction which is appropriate given the over-reporting of penicillin allergy. There are challenges with allergy data in ConnectCare, and standardized processes for updating inaccurate allergies are insufficient. The findings from the patient journey map are being incorporated with the data component from phase 2 of the project, to inform intervention planning and execution of KT activities. The findings also identified the need for decision algorithms for group B streptococcus and cesarean surgeries.